Enveric Biosciences Announces Artificial Intelligence Platform, PsyAI™, Has Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds

/PRNewswire/ -- Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental...

Related Keywords

Raquel Cona Joe Mcintyre ,Peter Facchini ,Valter Pinto Allison Soss ,Joseph Tucker ,Enveric Biosciences ,Enveric Psybrary ,Exchange Commission ,Company Annual Report On Form ,Strategic Communications ,Nasdaq ,Chief Scientific ,Annual Report ,Quarterly Reports ,